'Game-changing' cancer service approved for rollout
More cancer patients could receive genetic testing thanks to a new technique pioneered in Cambridge.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"Without the test, I would have needed much more complex surgery, and it would have taken even more time to recover."
— Laraine Chung , Other
"This is truly game-changing for our patients and for clinical practice."
— Dr. Jeffrey Rubasingham , Academic
"Whole genome sequencing can make a huge difference to a person's cancer journey, and it's vital that we remove barriers to testing so as many people as possible can benefit."
— Dr. John Tadross , Academic
Key People
A consultant clinical oncologist who used the new approach for cancer testing.
A consultant molecular pathologist at CUH who pioneered the change in testing.
A 63-year-old carer from Peterborough who underwent Whole Genome Sequencing for her tumor.
Tags
All Coverage
More cancer patients could receive genetic testing thanks to a new technique pioneered in Cambridge.
Similar Stories
Related coverage based on topic and tags
From weeks to hours - the rapid new test transforming brain tumour diagnosis
The test means patients can start treatment sooner and are spared weeks of uncertainty.
September 24, 2026 at 11:44 PMHow a rapid new test is helping brain tumour patients
A rapid new test for brain tumours that the NHS has started using can slash the time it takes for an accurate diagnosis from up to eight weeks to two hours.
September 25, 2026 at 06:50 AMFree counselling for blood cancer patients
Linc offers sessions online or in-person at The Forum in Gloucester to patients at any stage in their diagnosis, as well as their loved ones.
September 24, 2026 at 04:03 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PM'A tumour the size of a football saved my life'
Lisa Carroll, 47, who was diagnosed with rare form of ovarian cancer, urges women to check symptoms.
September 25, 2026 at 07:05 AM